Preclinical targeting of liver fibrosis with a <sup>89</sup>Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-β.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 12, p. 3545, doi. 10.1007/s00259-024-06785-9
- By:
- Publication type:
- Article